Contrast-enhanced echocardiographic measurement of longitudinal strain: accuracy and its relationship with image quality.


Journal

The international journal of cardiovascular imaging
ISSN: 1875-8312
Titre abrégé: Int J Cardiovasc Imaging
Pays: United States
ID NLM: 100969716

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 06 09 2019
accepted: 05 11 2019
pubmed: 14 11 2019
medline: 23 6 2020
entrez: 14 11 2019
Statut: ppublish

Résumé

The importance of left ventricular (LV) global longitudinal strain (GLS) is increasingly recognized in multiple clinical scenarios. However, in patients with poor image quality, strain is difficult or impossible to measure without contrast enhancement. The feasibility of contrast-enhanced GLS measurement was recently demonstrated. We sought to determine: (1) whether contrast enhancement improves the accuracy of GLS measurements against cardiac magnetic resonance (CMR) reference, (2) their reproducibility compared to non-enhanced GLS, and (3) the dependence of accuracy and reproducibility on image quality. We prospectively enrolled 25 patients undergoing clinically indicated CMR imaging who subsequently underwent transthoracic echocardiography (TTE) with and without low-dose contrast injection (1-2 mL Optison/3-5 mL saline IV, GE Healthcare). GLS was measured from both non-contrast and contrast-enhanced images using speckle tracking (EchoInsight, Epsilon Imaging). These measurements were compared to each other and to CMR reference values obtained using feature tracking (SuiteHEART, NeoSoft). Inter-technique comparisons included linear regression and Bland-Altman analyses. A random subgroup of 15 patients was used to assess inter- and intra-observer variability using intra-class correlation (ICC). Contrast-enhanced GLS was in close agreement with non-enhanced GLS (r = 0.95; bias: - 0.2 ± 1.5%). Both inter-observer (ICC = 0.88 vs. 0.82) and intra-observer variability (ICC = 0.91 vs. 0.88) were improved by contrast enhancement. The agreement with CMR was better for contrast-enhanced GLS (r = 0.87; bias: 1.1 ± 2.2%) than for non-enhanced GLS (r = 0.80; bias: 1.3 ± 2.7%). In 12/25 patients with suboptimal TTE images that rendered GLS difficult to measure, contrast-enhanced GLS showed better agreement with CMR than non-enhanced GLS (r = 0.88 vs. 0.83) and also improved inter-observer (ICC = 0.83 vs. 0.76) and intra-observer variability (ICC = 0.88 vs. 0.82). In conclusion, contrast enhancement of TTE images improves the accuracy and reproducibility of GLS measurements, resulting in better agreement with CMR, even in patients with suboptimal acoustic windows. This approach may aid in the assessment of LV function in this patient population.

Identifiants

pubmed: 31720940
doi: 10.1007/s10554-019-01732-4
pii: 10.1007/s10554-019-01732-4
pmc: PMC7316528
mid: NIHMS1565673
doi:

Substances chimiques

Albumins 0
Contrast Media 0
FS 069 0
Fluorocarbons 0

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

431-439

Subventions

Organisme : NHLBI NIH HHS
ID : T32 HL007381
Pays : United States

Références

Eur J Echocardiogr. 2011 May;12(5):394-9
pubmed: 21471046
Int J Cardiol. 2013 Aug 20;167(4):1625-31
pubmed: 22608891
J Cardiovasc Magn Reson. 2016 Jun 16;18(1):39
pubmed: 27306901
J Am Soc Echocardiogr. 2018 Mar;31(3):297-303
pubmed: 29174339
J Am Soc Echocardiogr. 2011 Mar;24(3):277-313
pubmed: 21338865
Eur J Radiol. 2017 Apr;89:72-80
pubmed: 28267553
Circ Cardiovasc Imaging. 2009 Sep;2(5):356-64
pubmed: 19808623
J Am Soc Echocardiogr. 2004 Oct;17(10):1021-9
pubmed: 15452466
J Am Soc Echocardiogr. 2010 Oct;23(10):1019-24
pubmed: 20810243
Eur Heart J Cardiovasc Imaging. 2016 Dec;17(12):1370-1378
pubmed: 27013249
J Am Soc Echocardiogr. 2015 Jan;28(1):1-39.e14
pubmed: 25559473
J Am Soc Echocardiogr. 2008 Jul;21(7):818-23
pubmed: 18222640
J Am Coll Cardiol. 2009 Aug 11;54(7):618-24
pubmed: 19660692
Eur J Echocardiogr. 2011 Jul;12(7):490-6
pubmed: 21636605
J Am Coll Cardiol. 2006 Mar 21;47(6):1175-81
pubmed: 16545649
Curr Probl Diagn Radiol. 2017 Jul - Aug;46(4):288-294
pubmed: 28063633
J Cardiovasc Magn Reson. 2016 Dec 5;19(1):8
pubmed: 28103933
Eur J Radiol. 2017 Apr;89:97-105
pubmed: 28267556
J Am Soc Echocardiogr. 2006 Jan;19(1):40-7
pubmed: 16423668
J Am Soc Echocardiogr. 2014 Sep;27(9):911-39
pubmed: 25172399
Eur Heart J Cardiovasc Imaging. 2015 Aug;16(8):871-81
pubmed: 25711353
Eur Heart J Cardiovasc Imaging. 2016 May;17(5):525-32
pubmed: 26377901
J Am Soc Echocardiogr. 2008 Nov;21(11):1179-201; quiz 1281
pubmed: 18992671
J Cardiovasc Magn Reson. 2015 Mar 10;17:25
pubmed: 25890093

Auteurs

Ilya Karagodin (I)

Department of Medicine, University of Chicago Medical Center, Chicago, IL, USA.

Davide Genovese (D)

Department of Medicine, University of Chicago Medical Center, Chicago, IL, USA.
Department of Cardiac Thoracic, and Vascular Sciences, University of Padua, Padua, Italy.

Eric Kruse (E)

Department of Medicine, University of Chicago Medical Center, Chicago, IL, USA.

Amit R Patel (AR)

Department of Medicine, University of Chicago Medical Center, Chicago, IL, USA.

Nina Rashedi (N)

Department of Medicine, University of Chicago Medical Center, Chicago, IL, USA.

Roberto M Lang (RM)

Department of Medicine, University of Chicago Medical Center, Chicago, IL, USA.

Victor Mor-Avi (V)

Department of Medicine, University of Chicago Medical Center, Chicago, IL, USA. vmoravi@bsd.uchicago.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH